This market research report presents an in depth analysis of High Throughput Screening (HTS).

• The research study emphasizes on both the technology and product segments of HTS in biotechnology and pharmaceutical application areas.
• The major technologies analyzed are Ultra High Throughput Screening, High Content/Cell Based Screening, Bioinformatics and Microfluidics / Lab-On-a-Chip.
• The major product segments encompass HTS Services and HTS Tools.
• Specific details about the global markets for novel / new High Throughput Screening Products and Cell Based Assays.
• Provides essential information about market data, market segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information.
• Lists 502 companies that are engaged in HTS services and / or production of HTS tools / instruments.
• Projections and estimates are graphically represented by region, by technology and by product segment. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific and rest of the world.
• The market reports are analyzed in US Dollars and includes 173 exclusive exhibits.
• Corporate Directory section covers Major Contract Research Organizations serving HTS industry.

Free Sample Research Report

Download Table of contents

Changing business paradigms brought in by globalization and liberalization are making pharmaceutical companies change strategies for sustenance and growth. Many companies are venturing into HTS studies instead of going for alliances, to become self sufficient and to reduce costs. The R&D wings are increasingly becoming target oriented to face the numerous challenges posed in the drug discovery and development industry.

Strategic partnerships between pharmaceutical and biotechnology companies are the order of the day, and the trend is increasing globally. Another significant trend is alliances between Pharma/Biotech and information technology companies such as Microsoft, IBM, Oracle, Sun, and Infosys, etc. The computer platforms generated by such companies help in managing and analyzing the huge amounts of data produced through HTS and other computational techniques. Effective R&D strategy involves efficient data management and implementation plans. The new technologies promise improved efficacy, decreased toxicity in patients, and reduced time periods and expenditures.

Global HTS growth is especially driven by the advancements in HTS technologies and the increasing usage of innovative techniques such as Bioinformatics and Microfluidics/Lab-on-a-Chip. The success of Human Genome Project and latest findings in genomics and proteomics are creating an enormous market for HTS by identifying huge number of drug targets. Currently, automation in HTS industry is in high gear. Companies are investing heavily in laboratory automation products such as HTS software, database systems, robotics arms, and robot based workstations.

Global High Throughput Screening market was an estimated US$11.3 billion in 2007. The United States dominates the market followed by Europe and the Asia Pacific region. Japan, owing to its efforts and progress in innovative technologies including Bioinformatics and Microfluidics, is fast gaining eminence. Due to the cost advantages and access to latest technologies, Contract Research Organizations (CROs) from across the globe, especially from the US and Europe, are establishing their facilities for basic drug research in the Asia Pacific region.

- Accelrys, Inc. (USA)
- Aurora Biomed, Inc. (Canada)
- BD Biosciences (USA)
- Beckman Coulter, Inc. (USA)
- Biacore International AB (Sweden)
- BioFocus DPI (UK)
- BioImage A/S (Denmark)
- BioImagene, Inc. (USA)
- Biotage AB (Sweden)
- Biotron Ltd. (Australia)
- Caliper Life Sciences, Inc. (USA)
- Cellomics, Inc. (USA)
- Cerep SA (France)
- Chemical Computing Group (Canada)
- ChemBridge Corporation (USA)
- Corning Life Sciences (USA)
- Deerac Fluidics (Ireland)
- DiscoveRx Corporation (USA)
- Evotec AG (Germany)
- GE Healthcare (UK)
- GeneVac Ltd. (UK)
- Hamamatsu Photonics K.K. (Japan)
- ID Business Solutions Ltd. (IDBS) (UK)
- Invitrogen Corporation (USA)
- Kibron, Inc. (Finland)
- Life Sciences Group, Hitachi, Ltd. (Japan)
- LION bioscience AG (Germany)
- Micronit Microfluidics BV (The Netherlands)
- Molecular Devices Corporation (USA)
- Monogram Biosciences, Inc. (USA)
- PerkinElmer, Inc. (USA)
- Sigma-Aldrich Corporation (USA)
- Tecan Group AG (Switzerland)
- Thermo Fisher Scientific, Inc. (USA)
- Tripos, Inc. (USA)
- TTP LabTech Ltd. (UK)
- Waters Corporation (USA)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	Provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the report summarizes the global market by HTS technologies - uHTS, High Content Screening, Bioinformatics and Lab-on-Chip. Global market is also analyzed by product segments including HTS Services, HTS Tools and Other HTS products and/or services. The chapter provides market values in US$ for each technology and product segment in several geographic regions including the US, Canada, Europe, Asia-Pacific and Rest of World.	$1000
III	Product / Technology Research	This chapter gives an insight into High Throughput Screening Technologies market including definitions, segmentation and applications. The chapter also provides market values in US$ (for the period 2005 through 2012) for HTS technologies and products. The chapter also includes product trends and potential opportunities. Global market shares of leading Cell based Assay players are also mentioned. Importance of HTS in the drug discovery process, technology analysis and technology trends are discussed.	$800
IV	Market Dynamics	Market Dynamics chapter provides information on global markets for HTS. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by both technology and product segment; a brief business profile of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches etc. Regions covered include the US, Canada, the UK, Germany, the Netherlands, Sweden, Switzerland, Belgium, Finland, Italy, Japan, China, and India. The chapter also includes market trends and an industry outlook.	$1500
V	Corporate Directory	This chapter provides a global region-wise list of 502 companies, CROs and academic institutions that are engaged in HTS products and/or services.	$300